is tirzepatide a glp-1 receptor agonist Tirzepatide, dual GIP/GLP-1 co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Effects of tirzepatide, a dual

Both are enabling weight loss on a scale weve never had with drugs before

Bays HE, Kirkpatrick CF, Maki KC, Toth PP, Morgan RT, Tondt J, et al

Focus on bland, easy-to-digest foods like crackers, toast, broth, applesauce, and cooked vegetables during the adjustment period, and avoid greasy, spicy, or heavy meals that can trigger or worsen nausea

Rapid weight loss itself can contribute to fatigue, independent of the medication mechanism

The reason tirzepatides effect on out-of-control eating was only temporary in this case is likely because the drug was designed and optimized for diabetes and weight loss, not for binge-eating disorders, Halpern surmised